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Summary
Background.— Severely depressed left ventricular ejection fraction (EF≤ 20%) has historically
been a major risk factor for morbidity and mortality in medically and surgically managed coro-
nary artery disease. Recent studies have suggested that outcomes in patients with EF less or
equal to 20% undergoing coronary artery bypass graft (CABG) surgery are improving, but the
trend in the outcomes remains unclear.
Methods.— We retrospectively analysed prospectively collected data from 2909 consecutive
patients undergoing isolated CABG between January 1998 and August 2006. One hundred and
eighty ﬁve patients (6.4%) had an ejection fraction less or equal to 20%. Primary outcome
measures for this study included hospital mortality, major postoperative complications, and
long-term survival.
Results.— The median age in the overall patient population was 65 years (interquartile range
58—73) and 69% (n = 2015) of patients were male. The overall hospital mortality among our
study population was 2.3% (n = 67). The mortality among patients with EF less or equal to 20
was 5% (n = 11) compared to 2% (n = 56) in patients with EF above 20% (p = 0.001). The proportion
of patients with a high EuroSCORE (> 9%) was signiﬁcantly greater in the group with EF less or
equal to 20% (49%) than in the group with EF above 20% (20%). EF less or equal to 20% was not
shown by multivariable logistic regression analysis to be an independent predictor of operative
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inférieure ou égale à 20% est acceptable. La FEVG inférieure ou égale à 20% n’apparaît pas
être un facteur de mortalité opératoire dans notre exercice. Des améliorations sur la prise en
charge des patients et des changements sur les indications ont permis de réduire l’impact des
sur la
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n patients with symptomatic multivessel coronary artery
isease and severely depressed left ventricular (LV) func-
ion (ejection fraction [EF] less or equal to 20%), coronary
rtery bypass graft (CABG) surgery is the optimal therapeu-
ic approach and remains superior to medical therapy [1—4].
he postoperative outcome of these patients has tradition-
lly been worse than that of patients with moderate to good
V function [5,6]. More recent data, however, which report
hat EF less or equal to 20% does not appear to be an inde-
endent risk factor for operative mortality following CABG,
ndicates that incremental improvements in peroperative
anagement and operative technique may have substan-
ially reduced the negative impact of severely depressed LV
unction on early outcome [7].
There is, however, little data with respect to whether
his is true for patients with very severely depressed LV
unction (EF≤ 20%). Furthermore, the predictors of out-
ome in this high-risk group of patients are poorly deﬁned,
ainly because of the small number of individuals included
n the majority of previous studies. Most clinical series have
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Emortalité après chirurgie de pontages coronaires.
rights reserved.
ocused primarily on early operative mortality and morbid-
ty, and there is little data describing long-term survival
n this patient population. Herein, we report our clinical
xperience in a large, contemporary single centre series
f patients with very severely depressed LV function who
nderwent CABG between 1998 and 2006. In this study we
ought to determine the early outcome, predictors of early
ortality and major postoperative complications as well as
id-term survival and predictors of late mortality following
oronary revascularization in this patient population.
aterials and methods
tudy population
e analysed a series of 2937 patients undergoing isolatedF. Filsouﬁ et al.
mortality. Survival rates at one year were 85± 2.8%, 93± 0.9%, and 98%± 0.3% for patients
with EF less or equal to 20%, over 20—40% and greater than 40% respectively; and at ﬁve years:
72± 0.4%, 81± 0.2% and 89± 0.1%, respectively (p < 0.001).
Conclusion.— We demonstrate acceptable mortality rates in patients with an EF less or equal
to 20%, and show that EF less or equal to 20% does not appear to be an independent predictor of
hospital mortality in our practice. Incremental changes in practice including improved patient
selection and peroperative management may have reduced the impact of EF less or equal to
20% on mortality following CABG.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé
Introduction.— La fraction d’éjection (FEVG) très basse a toujours été un facteur de risque
majeur de morbidité et mortalité chez les patients coronariens traités médicalement ou chirur-
gicalement. Des études récentes ont suggéré que le devenir des patients dont la FEVG inférieure
ou égale à 20% s’améliorait dans la dernière décade mais la tendance n’est pas certaine.
Méthode.— Nous avons analysé de manière rétrospective les données de 2909 patients consé-
cutifs opérés de pontages coronaires isolés entre janvier 1998 et août 2006. Cent quatre-vingt
cinq patients (6,4 %) avaient une fraction d’éjection inférieure ou égale à 20%. Les données
concernant la mortalité et la morbidité opératoires ainsi que la survie à long terme ont été
analysées.
Résultats.— L’âge moyen était de 65 ans (écart interquartile 58—73 ans) et 69% (n = 2015)
étaient des hommes. La mortalité opératoire globale était de 2,3% (n = 67), 5 % (n = 11) dans le
groupe de patients avec une FEVG inférieure ou égale à 20% et 2% (n = 56) chez les patients avec
une FEVG supérieure à 20% (p = 0,001). La proportion de patients avec un Euroscore supérieur
à 9 était signiﬁcativement plus importante chez les patients avec une FEVG inférieure ou égale
à 20% (49 % versus 20 %). La FEVG inférieure ou égale à 20% n’était pas un facteur prédictif
indépendant de mortalité opératoire en analyse multivariée. Les survies à un an des groupes
avec une FEVG inférieure ou égale à 20%, FEVG entre 20 et 40 % et FEVG supérieure à 40%
étaient de 85± 2,8 %, 93± 0,9 % et 98± 0,3 % et les survies à cinq ans de 72± 0,4 %, 81± 0,2 %
et 89± 0,1 %, respectivement.
Conclusion.— La mortalité opératoire des pontages coronaires chez les patients avec une FEVGABG procedures at the Mount Sinai Medical Center between
anuary 1998 and August 2006. Data were collected prospec-
ively and analysed retrospectively.
The study group was determined by the preoperative
F. Patients with an EF less or equal to 20% formed the
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study group, whereas those with an EF above 20% served
as the control group. Patients undergoing reoperations
or emergent procedures were included in this analysis.
Patients admitted in cardiogenic shock undergoing a sal-
vage procedure were excluded (n = 28). Preoperative EF was
assessed by echocardiography (n = 2240, 77%), LV angiogra-
phy (n = 640, 22%), and radionuclide studies (n = 29, 1%).
The protocol was approved by our local institutional
review board and was compliant with the Health Insur-
ance Portability and Accountability Act regulations and the
ethical guidelines of the 1975 Declaration of Helsinki. The
approval included a waiver of informed consent.
Data collection and outcome analysis
Clinical variables were entered prospectively into the New
York State Department of Health (NYSDH, State Cardiac Advi-
sory Committee) data registry. This registry represents a
mandatory, veriﬁed, peer-reviewed data-collection system
including all adult cardiac surgery procedures in the state
of New York, and records and analysed data in a strictly
supervised and widely reported fashion.
Patient demographics and risk factors, operative infor-
mation and postoperative outcome data were analysed
retrospectively. Additional information was obtained from
patient charts when necessary. In addition, the logis-
tic EuroSCORE was used for risk stratiﬁcation [8]. The
EuroSCORE is a risk-stratiﬁcation system using multiple pre-
operative risk factors to predict operative mortality. Low
to moderate risk was deﬁned as a predicted mortality by
EuroSCORE less or equal to 9%, whereas high risk was deﬁned
as a EuroSCORE above 9%.
Outcome measures for this study included hospital mor-
tality, major postoperative complications (peroperative
myocardial infarction, respiratory failure, renal failure,
deep sternal wound infection, bleeding requiring reoper-
ation, unplanned reoperation, stroke, and gastrointestinal
complications), length of hospital stay and late survival.
Hospital mortality was deﬁned as death following the pro-
cedure before the patient’s discharge regardless of the
duration of hospitalization. Patients who died after dis-
charge from hospital but within 30 days following the
procedure were also considered as hospital deaths. Respi-
ratory failure was deﬁned as prolonged ventilator therapy
(> 72 hours) or need for reintubation or tracheostomy. Renal
failure was deﬁned as creatinine above 2.5mg/dL for more
than seven postoperative days or the need for dialysis.
Myocardial infarction was deﬁned as the occurrence of a new
Q-wave within 48 hours after surgery. Stroke was deﬁned as
a new permanent neurological event occurring peri- or post-
operatively. Follow-up survival information was obtained by
cross matching patients’ social security numbers with the
web-based social security death index.
Surgical management
All patients underwent a median sternotomy. Eighty six per
cent (n = 2493) of procedures were performed utilizing car-
diopulmonary bypass (CPB). The remaining 14% (n = 416)
of procedures were performed without the use of CPB
(off-pump coronary artery bypass, OPCAB). Since 2003,
epiaortic ultrasonography was performed systematically in
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ll patients to detect any atherosclerotic lesions of the
scending aorta prior to cannulation and clamping. The
urgical strategy was tailored according to the presence
r absence of calciﬁcation in the ascending aorta and its
xtent.
n-pump coronary revascularization
fter systemic heparinization with an activated clotting
ime (ACT) level of at least 400 seconds, CPB was insti-
uted between the ascending aorta and the right atrium
sing a two-stage cannula. Following aortic cross-clamp
lood cardioplegia was administered in an antegrade and/or
etrograde fashion. Since 2003, we routinely administered
solution of antegrade warm blood cardioplegia before
emoval of the aortic cross clamp (‘‘hot-shot’’ cardiople-
ia). Distal anastomoses were completed ﬁrst followed by
roximal anastomoses using the single aortic cross-clamp
echnique [9]. The left internal thoracic artery was routinely
nastomosed to the left anterior descending artery. The aor-
ic cross clamp was then released and the patients weaned
rom CPB after a short period of reperfusion. After the com-
letion of CPB, protamine was given based on the heparin
evel.
ff-pump coronary revascularization
he procedure was performed based on the surgeon’s prefer-
nces. This technique, however, was favoured particularly
n patients with signiﬁcant atherosclerotic disease of the
scending aorta. In patients undergoing OPCAB, heparin
as administered to achieve an ACT of 300 seconds. Coro-
ary stabilizer and cardiac positioning devices were used
o access the coronary arteries under beating heart con-
itions. Intracoronary shunts were used systematically in
ll patients, in order to prevent prolonged myocardial
schaemia while distal anastomoses were created. Following
ompletion of the procedure, protamine was administered
ased on the heparin level.
tatistical analyses
ormally distributed continuous variables are presented as
ean± standard deviation (SD) and otherwise as median and
nterquartile range (IQR). Categorical variables are shown
s the percentage of the sample. A p-value less than 0.05
as considered as signiﬁcant for all used statistical methods.
he 2-test was used to evaluate potential confounders of
he relationship between low EF and hospital mortality and
orbidities. Stepwise multivariable logistic regression was
hen performed to assess the inﬂuence of low EF as an inde-
endent risk factor for hospital mortality and postoperative
orbidities [10]. In patients with low EF, univariate and mul-
ivariable analyses were performed in the same manner to
dentify predictors of hospital mortality and late mortality.
The potential confounders introduced into multivariable
nalysis included age, sex, diabetes mellitus, congestive
eart failure, previous cardiac procedure, body mass index,
ypertension, myocardial infarction, chronic obstructive
ulmonary disease, peripheral vascular disease, renal fail-
re, hepatic failure, urgency of procedure and use of
nternal mammary artery.
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Table 1 Patient demographics and risk factors (n = 2909).
EF≤ 20% (n = 185, 6.4%) EF > 20% (n = 2724, 93.6%) p
Mean age (years) 64± 10 66± 11 NS
Women, n (%) 54 (29) 840 (31) NS
Mean body mass index (kg/m2) 26± 5 27± 5 0.003
Body mass index > 30 kg/m2, n (%) 31 (17) 652 (24) 0.017
Mean ejection fraction (%) 16± 4 48± 12 0.001
Congestive heart failure, n (%) 118 (64) 398 (15) 0.001
Previous myocardial infarction, n (%) 149 (80) 1280 (47) 0.001
Previous cerebrovascular accident, n (%) 18 (10) 219 (8) NS
Peripheral vascular disease, n (%) 35 (20) 345 (13) 0.006
Diabetes, n (%) 81 (45) 1083 (40) NS
COPD, n (%) 16 (9) 172 (6) NS
Renal failure or dialysis, n (%) 14 (9) 123 (5) 0.015
Hypertension, n (%) 140 (75) 2155 (79) NS
Aortic calciﬁcation-atherosclerosis, n (%) 9 (5) 133 (5) NS
Previous cardiac operation, n (%) 11 (6) 96 (4) NS
Previous PCI, n (%) 22 (12) 546 (20) 0.021
Coronary artery disease, n (%) NS
One vessel 27 (15) 240 (11)
Two vessel 36 (20) 496 (18)
Three vessel 122 (65) 1938 (71)
Emergent surgery, n (%) 21 (12) 131 (5) 0.001
Mean EuroSCORE (%) 14± 12 6± 7 0.001
Low (< 3%) 4 (3) 1050 (38)
Moderate (3—9%) 91 (48) 1143 (42)
High (9—25%) 63 (35) 446 (16)
Very high (> 25%) 27 (14) 85 (4) 0.001
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Long-term survival of discharged patients was analysed
sing Kaplan-Meier survival curves. These analyses included
he impact of low EF on survival following CABG in the over-
ll population and the effect of preoperative risk factors and
uroSCORE on survival in the low EF group. Differences in
atient characteristics were controlled by Cox proportional
azard analysis. The statistical analyses were performed
ith the use of SPSS 15 (SPSS Inc., Chicago, Il, USA).
esults
emographic data and preoperative risk
actors
he median age in the overall patient population was 65 (IQR
8—73) years and 69% (2015 of 2909) of patients were male.
ery severely depressed LV function (EF≤ 20%) was present
n 185 (6.4%) patients.
There were signiﬁcant differences in preoperative
omorbidities between patients with EF less or equal to
0% and patients with EF above 20% (Table 1). Patients with
F less or equal to 20% were more likely to present with
ongestive heart failure (p < 0.001), a history of myocar-
ial infarction (p < 0.001) or as an emergency (p < 0.001),
nd were more likely to have additional risk factors includ-
ng peripheral vascular disease (p < 0.006) and renal failure
T
w
w
E
pary intervention.
p < 0.015). The proportion of patients with a high or very
igh EuroSCORE (logistic EuroSCORE > 9%) was signiﬁcantly
reater in the EF less or equal to 20% group compared with
he EF greater than 20% group (49% versus 20%, p = 0.001).
perative characteristics
PCAB was performed in 12% (n = 24) of low EF patients and
n 14% (n = 392) of patients with normal LV function. The
umber of grafts in the low EF and control groups were
.0± 1.4 and 3.2± 1.3, respectively, (p =NS). Patients with
epressed LV function received signiﬁcantly fewer inter-
al mammary artery bypass grafts (n = 123, 65%) compared
o the control group (n = 2074, 76%; p = 0.003). The cross
lamp times were not signiﬁcantly different between groups
Table 2). Twenty patients in the EF less than 20% group
equired an intra-aortic balloon pump (IABP; 10.8%) pre-
r postoperatively, while 125 patients in the EF above 20%
roup had an IABP inserted (p = 0.001).
ortalityhe overall hospital mortality among our study population
as 2.3% (n = 67). The mortality among low EF patients
as 5.0% (n = 11) compared to 2.0% (n = 56) in those with
F above 20% (p = 0.001). For information, during the study
eriod, 898 patients underwent non-emergent coronary
CABG in patients with ejection fraction less than 20% 551
Table 2 Operative data.
EF≤ 20% (n = 185, 6.4%) EF > 20% (n = 2724, 93.6%) p
Off-pump procedures 24 (12) 392 (14) NS
Mean number of grafts 3.0± 1.4 3.2± 1.3 NS
Use of left mammary artery, (%) 123 (65) 2074 (76) 0.003
Use of bilateral mammary arteries, (%) 6 (3) 308 (11) 0.001
Cardiopulmonary bypass time (min) 113± 51 104± 54 NS
p
c
(
l
r
c
9
oAortic cross-clamp time (min) 87± 74
bypass associated with other surgical procedures. In this
particular population, operative mortality was 8.9% among
patients with low EF (n = 90) and 6.7% among those with EF
above 20% (n = 808).
Analysis of mortality rates over to two different periods
(1998—2002 versus 2003—2006) showed that surgical mortal-
ity improved from 6.9% to 3.7% (p = 0.33) in the EF less than
20% group and from 2.8% to 1.2% (p = 0.002) in the control
group.
Table 3 shows the risk factors for hospital mortality in the
overall population after multivariable analysis. The pres-
ence of EF less or equal to 20% was not an independent
L
a
h
Figure 1. Kaplan-Meier survival curves. A. Adjusted for age, body ma
chronic obstructive pulmonary disease by ejection fraction strata. B. Un82± 46 NS
redictor of hospital mortality (odds-ratio [OR] 1.39, 95%
onﬁdence interval [CI] 0.60—3.18, p = 0.441). Renal failure
OR 3.31, 95% CI 1.44—7.61, p = 0.005), peripheral vascu-
ar disease (OR 1.28, 95% CI 1.27—4.44, p = 0.007), cardiac
eoperation (OR 4.13, 95% CI 1.64—10.82, p = 0.003) and a
ardiopulmonary bypass time above 120minutes (OR 2.47,
5% CI 1.13—5.39, p = 0.023) were independent predictors
f hospital mortality.The number of patients with very severely depressed
V function was too small to allow multivariable regression
nalysis to determine accurately independent predictors of
ospital mortality.
ss index, congestive heart failure, peripheral vascular disease and
adjusted survival curves.
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Table 3 Predictors of hospital mortality in multivariable analysis.
Variable Multivariate
OR 95.0% CI p
Gender (female) 2.41 (1.35—4.30) 0.010
Age > 70 years 1.09 (0.60—1.99) 0.776
Ejection fraction≤ 20% 1.39 (0.60—3.18) 0.441
BMI > 30 1.15 (0.60—2.22) 0.672
Congestive heart failure 1.89 (1.00—3.57) 0.050
Previous myocardial infarction 1.40 (0.76—2.58) 0.280
Previous stroke 0.73 (0.25—2.17) 0.571
Peripheral vascular disease 1.28 (1.27—4.44) 0.007
Diabetes mellitus 1.28 (0.71—2.27) 0.412
COPD 0.72 (0.24—2.17) 0.555
Renal failure 3.31 (1.44—7.61) 0.005
IABP 3.85 (1.44—7.61) 0.002
Hemodynamic unstability 2.29 (0.79—6.61) 0.125
Hypertension 1.66 (0.68—4.01) 0.264
Reoperation 4.13 (1.64—10.82) 0.003
X-Clamp Time> 80 min 0.87 (0.39—2.04) 0.740
CPB Time > 120 min 2.47 (1.13—5.39) 0.023
BMI: body mass index; CI: conﬁdence interval; COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass; IABP:
intra-aortic balloon pump; OR: odds-ratio.
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ostoperative complications following CABG among the
verall study population included stroke (n = 47, 1.6%),
yocardial infarction (n = 22, 0.8%), renal failure requir-
ng dialysis (n = 27, 0.9%) deep sternal wound infection
n = 40, 1.4%) sepsis (n = 43, 1.5%), reoperation for bleed-
ng (n = 57, 1.9%) and respiratory failure (n = 176, 6.0%).
atients with EF less or equal to 20% had a signiﬁcantly
igher rate of postoperative renal failure (p = 0.027), and
epsis (p = 0.001) compared to patients with normal LV func-
ion (Table 4). In multivariable logistic regression analysis
F less or equal to 20% was shown to be an independent
redictor of postoperative renal failure (OR 2.74, 95% CI
.06—5.84, p = 0.042) and sepsis (OR 3.71, 95% CI 1.60—8.60,
= 0.002) (Table 5).
ong-term survival
he mean follow up time was 4.2± 2.5 years. Long-term
urvival of discharged patients was signiﬁcantly decreased
n patients with severely depressed LV function compared to
hose with EF above 20% (Figs. 1 and 2). One-year survival
ates were 85± 2.8%, 93± 0.9%, and 98± 0.3% for patients
ith EF less or equal to 20%, above 20—40% and above
0%, respectively; ﬁve-year survival rates were 72± 0.4%,
1± 0.2% and 89± 0.1%, respectively (p < 0.001). Late sur-
ivors were signiﬁcantly less likely than non-survivors
o have a very high preoperative predicted risk by the
uroSCORE (12% versus 23%, respectively, p = 0.009). The
umbers of patients were too small to permit multivariable
nalysis determining whether EuroSCORE was an indepen-
ent predictor of late mortality.
D
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migure 2. Late survival Kaplan-Meier curves in the low ejection
raction group by EuroSCORE strata (ES).
iscussionhis is one of the largest, contemporary, single-centre
eries analysing the outcomes of patients with very severely
epressed LV function (EF≤ 20%) undergoing CABG. The
ain ﬁndings of this study include a very low operative
CABG in patients with ejection fraction less than 20% 553
Table 4 Mortality and morbidities in the overall population (n = 2909).
EF≤ 20% (n = 185, 6.4%) EF > 20% (n = 2724, 93.6%) p
Hospital mortality 11 (5) 56 (2) 0.001
Morbidities
Postoperative stroke 5 (3) 42 (1) NS
Postoperative myocardial infarction 4 (2) 18 (1) 0.049
Postoperative renal failure-dialysis 5 (3) 22 (1) 0.027
Respiratory failure 27 (14) 149 (5) 0.001
Deep sternal wound infection 3 (2) 37 (1) NS
Postoperative systemic infection 10 (5) 33 (1) 0.001
Re-exploration for bleeding 9 (5) 48 (2) 0.010
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DGastrointestinal complications 3 (2)
Length of stay in days (interquartile range) 9 (6—15
mortality in this group of high-risk patients. We show that
very severely depressed LV function does not appear to
be an independent predictor of early mortality in patients
undergoing CABG in our practice, although it remains an
independent risk factor for major morbidity postoperatively
and for late mortality. We show for the ﬁrst time that the
EuroSCORE is an accurate predictor of long-term survival in
this high-risk group of patients.
Prevalence of low EF in CABG patients
The reported prevalence of severe LV dysfunction in patients
undergoing CABG in large series and registries has ranged
from 3.4—15% [6,11], reﬂecting the fact that deﬁnitions
of LV dysfunction vary widely, with most studies choosing
an EF of less or equal to 30% [6,11—18], and a few using
higher values [19,20]. Both Parsonnet and EuroSCORE risk-
stratiﬁcation systems deﬁne poor ventricular function as an
EF less than 30% [5]. Improving outcomes in patients with
borderline poor ventricular function has focused attention
on the results of surgery in patients at the most compro-
mised end of the scale, with EF less or equal to 20%. The
prevalence of EF less or equal to 20% in an analysis of a
large registry of patients undergoing CABG between 1990
and 2001 ranged between 2.3 and 3.1% [7]. The preva-
lence of EF less or equal to 20% in our cohort of patients
was over double this at 6.4%, which may reﬂect the con-
tinuing wider trend of higher numbers of patients with
very severely LV dysfunction being referred for cardiac
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Table 5 Multivariable logistic regression analysis of EF less tha
morbidities.
Multiv
OR
Postoperative stroke 0.35
Postoperative myocardial infarction 2.75
Postoperative renal failure—dialysis 2.74
Respiratory failure 2.89
Deep sternal wound infection 4.50
Postoperative systemic infection 3.71
Reexploration for bleeding 2.55
Gastrointestinal complications 1.3426 (1) NS
6 (5—9) 0.001
urgery [21], as well as a referral bias at our institu-
ion.
ortality and morbidity
atients with very severe LV dysfunction undergoing CABG
ave been consistently shown in the literature to have higher
perative mortality and reduced long-term survival com-
ared to patients with normal or mildly impaired LV. The
ospital mortality reported in patients with EF less or equal
o 30% during the late 1980s was as high as 20% [1,22]. This
as decreased signiﬁcantly: the majority of series of patients
ith low EF undergoing CABG in the 1990s reported early
ortalities between 5 and 15% [3,6,7,11—14,19,23—28],
hereas the majority of series describing results in patients
perated on after 2000 were reporting mortalities of less
han 5% [17,29].
Few contemporary studies report the results of CABG in
atients with EF less or equal to 20%. The mortality reported
n patients operated on between 1997 and 1999 by the New
ork State cardiac surgery database study was 6.5% in hos-
ital, with a 4.6% early mortality in patients with EF less or
qual to 20% [6]. More recent data from the registry study by
aveierwala et al. reported a hospital mortality rate of 8.9%
n this group of patients operated on between 1998 and 2001,
ompared to 10.9% in patients operated on between 1990
nd 1993 [7]. Our results comparing two periods of surgical
ractice (1998—2002 versus 2003—2006) reﬂect the improve-
ent in mortality reported in the literature in recent years,
n 20% as an independent predictor of major postoperative
ariate
95.0% CI p
(0.43—2.78) 0.318
(0.71—10.49) 0.139
(1.06-5.84) 0.042
(0.93—1.64) 0.087
(0.33—1.28) 0.758
(1.60—8.60) 0.002
(0.83—6.11) 0.111
(0.35—5.15) 0.666
5 F. Filsouﬁ et al.
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ven if it was not statistically signiﬁcant in the EF less than
0% group, probably due to the small sample size.
This improvement in operative outcome is certainly
ultifactorial and probably related to improvements in
yocardial protection strategies and perioperative manage-
ent of related comorbidities, as well as improved case
election involving myocardial viability studies. During the
tudy period intraoperative epiaortic and transoesophageal
chocardiography, blood cardioplegia with warm induction
nd reperfusion, and modern postoperative management
rotocols became standard adjuncts to surgical practice.
espite the fact that our study was not designed to give
nformation with respect to the many incremental changes
n operative and perioperative management that occurred
ince its inception, we believe that these have made a sig-
iﬁcant contribution to the reduction in operative mortality.
EF less or equal to 20% was not shown by multivariable
ogistic regression analysis of our patient database to be an
ndependent risk factor for early mortality (OR 1.39, 95%
I 0.60—3.18, p = 0.44). Historically, severely depressed LV
unction has been identiﬁed as an independent risk factor
or early mortality [7,30,31]. Recent studies have suggested
hat the signiﬁcance severely depressed LV function as a
redictor of mortality may be decreasing: OR for severely
epressed LV function did not reach statistical signiﬁcance
n multivariable logistic regression analysis of two large,
ontemporary series of patients. The differences in deﬁni-
ions of severely depressed LV may partly account for this
Hillis et al. [19] included patients with EF less or equal to
5%). The study by Davierwala et al., [7] however, which
ooked at a registry of patients undergoing CABG over three
ime periods between 1990 and 2001, and which deﬁned
everely depressed LV function as EF less than 20% showed
hat the impact of EF less than 20% on early mortality
eclined across the three periods, so that in the third it was
o longer an independent predictor by multivariable analy-
is of hospital mortality. This decline in the predictive value
f severely depressed LV function lends further support to
he hypothesis that evolution in case selection, operative
nd perioperative management has signiﬁcantly improved
utcomes in these traditionally high risk patients.
Severely depressed LV function has previously been asso-
iated with postoperative respiratory failure, renal failure
nd dialysis, sepsis and gastrointestinal problems [6,30]. Our
nalysis showed that patients with EF less or equal to 20%
ndergoing CABG had a signiﬁcantly higher rate of post-
perative respiratory failure (p < 0.05) and sepsis (p < 0.05)
han patients with EF above 20%, and multivariable logistic
egression analysis conﬁrms that EF less or equal to 20% was
n independent risk factor for these complications in our
atient group.
ong-term survival
atients with EF less or equal to 20% in our study had an
ctuarial one-year survival of 85.0%, and a ﬁve-year survival
f 72.7%, signiﬁcantly poorer than that of patients with EF
bove 20%. When divided into a high- and lower-risk group
y logistic EuroSCORE, patients with a low to moderate
redicted risk (< 9%) by EuroSCORE had one- and ﬁve-year
urvivals of 88 and 76%, respectively, compared to 82% and
0%, respectively, for patients with EuroSCORE above 9%
a
ﬁ
t
f
iigure 3. Late-survival Kaplan-Meier curves by age strata.
p < 0.001; Fig. 2). These ﬁgures are at the upper limit of
he long-term survival data recorded in the literature. One-
ear survivals reported in single centre and registry studies
nalysing patients with EF less or equal to 30 undergoing
ABG within the past decade range from 81 to 92% [17],
hree-year survival ranges from 68 [32] to 87% [17], and
ve-year survival where reported ranges from 45 [32] to
8% [16]. The strongest predictors of mortality during long-
erm follow-up were age greater or equal to 65 years and a
istory of chronic obstructive pulmonary disease, with less
han half of patients in the EF less or equal to 20% group
ith either of these risk factors surviving more than 5 years
Table 6, Figs. 3 and 4). It appears from these ﬁgures that the
ncreasingly high-risk patient proﬁle may negate any beneﬁt
n long-term survival gained by improvements in early out-
ome. Comparative data from the literature are, however,
ot risk adjusted and comparisons are therefore difﬁcult to
ake.
imitations
his is the one of the largest contemporary, single-centre
nalyses of outcomes in patients with EF less or equal to
0% undergoing CABG. This study does, however, present
ertain limitations. Firstly, given that this is a retrospec-
ive observational study, conclusions are necessarily limited
n their application. Secondly, clinical outcomes are lim-
ted to major postoperative morbidity and mortality with
o information on late complications, quality of life, cause
f death during follow-up, postoperative EF (including mea-
ures of improved myocardial viability) or cost-analysis. The
ack of data with respect to speciﬁc changes in operative
nd peroperative practice makes it difﬁcult to draw any
rm conclusions that could direct future practice. Finally,
he wide variation in deﬁnitions of severely depressed LV
unction highlighted above, as well as the lack of risk strat-
ﬁcation in the literature means that it is difﬁcult to draw
CABG in patients with ejection fraction less than 20% 555
Table 6 Late-survival patient characteristics.
All patients(n = 174) Alive(n = 121) Died(n = 53) p
Mean age (years) 64± 10 62.9± 10.6 67.9± 10.9 0.004
Women, n (%) 48 (28) 30 (25) 18 (34) NS
Mean body mass index (kg/m2) 26± 5 26.7± 5.1 25.1± 4.4 0.046
Body mass index > 30 kg/m2, n (%) 29 (17) 23 (19) 6 (11) NS
Congestive heart failure, n (%) 110 (63) 71 (59) 39 (73) 0.043
Previous myocardial infarction, n (%) 139 (80) 94 (78) 45 (85) NS
Previous cerebrovascular accident, n (%) 18 (10) 10 (8) 8 (15) NS
Peripheral vascular disease, n (%) 31 (18) 16 (13) 15 (28) 0.017
Diabetes, n (%) 75 (43) 53 (44) 22 (41) NS
COPD, n (%) 15 (9) 6 (5) 9 (17) 0.013
Renal failure or dialysis, n (%) 13 (7) 9 (7) 4 (7) NS
Hypertension, n (%) 130 (75) 90 (74) 40 (75) NS
Aortic calciﬁcation-atherosclerosis, n (%) 8 (5) 2 (2) 6 (12) 0.011
Previous cardiac operation, n (%) 19 (10) 15 (12) 4 (8) NS
Previous PCI, n (%) 22 (12) 16 (12) 6 (11) NS
Coronary artery disease, n (%) NS
One vessel 24 (14) 13 (11) 11 (20)
Two vessel 37 (21) 26 (21) 11 (17)
Three vessel 113 (65) 82 (68) 31 (63)
Emergent surgery, n (%) 19 (11) 13 (11) 6 (11) NS
Mean EuroSCORE (%) 14± 12 12± 12 17± 11 0.020
Low (< 3%) 4 (2) 3 (2) 1 (2)
Mod (3—9%) 85 (49) 69 (57) 16 (30)
High (9—25%) 62 (36) 37 (31) 25 (47)
Very high (> 25%) 23 (13) 12 (10) 11 (21) 0.009
COPD: chronic obstructive pulmonary disease; NS: not signiﬁcant; PCI:
Figure 4. Late-survival Kaplan-Meier curves by chronic obstruc-
tive pulmonary disease strata.
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Rpercutaneous coronary intervention.
ccurate comparisons between the outcomes of studies in
his area.
onclusion
xcellent results following CABG can be expected in patients
ith EF less or equal to 20%, with minimal increases in post-
perative morbidity and mortality. Contemporary results in
his high-risk patient group are substantially better than his-
orical reports despite a substantial increase in the burden
f comorbidities and predicted mortality. Very low EF does
ot appear to be an independent risk factor for early mortal-
ty, but long-term survival is still signiﬁcantly reduced when
ompared with patients with EF above 20%. Careful preop-
rative selection and peroperative management, including
ptimal strategies of myocardial preservation, is essential
n patients with EF less or equal to 20% undergoing cardiac
urgery.
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